Nonclinical service CRO Envigo is merging with publicly traded Avista Healthcare Public Acquisition Corporation.
Charles River Laboratories is buying CRO Brains On-Line for €18 million as it further strengthens its offers in CNS early-stage drug research.
PRA will buy health data and analytics expert Symphony Health for $530 million up front as it reports 16% second-quarter service revenue growth.
Icon strengthens real-world evidence offerings by acquiring health research and commercialization company Mapi.
German CRO Evotec is acquiring U.S. counterpart Aptuit in a $300 million deal.
Science Exchange has raised $28 million in its third funding round.
WuXi Biologics is pricing its shares at HK$20.60, the top end of its marketing range, valuing the IPO at $510 million, Bloomberg reports.
Outcome Health, a healthcare intelligence tech firm, has raised an outsize $500 million first round of funding, valuing it at $5.5 billion.
Medical device-focused CRO Genae has invested an undisclosed amount in Meditrix, a Japanese CRO in that same field, and obtained a call option to acquire the…
Chiltern has acquired Japanese CRO Integrated Development Associates (IDA), strengthening its presence in Asia.